| The multifaceted roles of osteopontin in cell signaling, tumor progression and angiogenesis G Chakraborty, S Jain, R Behera, M Ahmed, P Sharma, V Kumar, ... Current molecular medicine 6 (8), 819-830, 2006 | 164 | 2006 |
| Discovery and characterization of small molecules that target the GTPase Ral C Yan, D Liu, L Li, MF Wempe, S Guin, M Khanna, J Meier, B Hoffman, ... Nature 515 (7527), 443-447, 2014 | 154 | 2014 |
| Osteopontin selectively regulates p70S6K/mTOR phosphorylation leading to NF-κB dependent AP-1-mediated ICAM-1 expression in breast cancer cells M Ahmed, GC Kundu Molecular cancer 9, 1-13, 2010 | 101 | 2010 |
| Osteopontin: a potentially important therapeutic target in cancer M Ahmed, R Behera, G Chakraborty, S Jain, V Kumar, P Sharma, ... Expert opinion on therapeutic targets 15 (9), 1113-1126, 2011 | 86 | 2011 |
| An osteopontin/CD44 axis in RhoGDI2-mediated metastasis suppression M Ahmed, JL Sottnik, GM Dancik, D Sahu, DE Hansel, D Theodorescu, ... Cancer cell 30 (3), 432-443, 2016 | 75 | 2016 |
| Structural basis for ligand reception by anaplastic lymphoma kinase T Li, SE Stayrook, Y Tsutsui, J Zhang, Y Wang, H Li, A Proffitt, SG Krimmer, ... Nature 600 (7887), 148-152, 2021 | 26 | 2021 |
| Identification of a biologically active fragment of ALK and LTK-Ligand 2 (augmentor-α) AV Reshetnyak, J Mohanty, F Tomé, DE Puleo, AN Plotnikov, M Ahmed, ... Proceedings of the National Academy of Sciences 115 (33), 8340-8345, 2018 | 20 | 2018 |
| A hypothalamic pathway for Augmentor α–controlled body weight regulation M Ahmed, N Kaur, Q Cheng, M Shanabrough, EO Tretiakov, T Harkany, ... Proceedings of the National Academy of Sciences 119 (16), e2200476119, 2022 | 10 | 2022 |
| Therapeutic targeting of osteopontin in breast cancer cells GC Kundu Edited by Esra Gunduz and Mehmet Gunduz, 23, 2011 | 4 | 2011 |
Goutam ChakrabortyIcahn School of Medicine at Mount Sinai, New YorkVerified email at mountsinai.org
